BioSpace News Archive

Drug Development

GenSight Biologics Receives MHRA Approval to Initiate Phase I/II PIONEER Clinical Trial of GS030 Gene Therapy in Retinitis Pigmentosa

The primary outcome analysis will be the safety and tolerability at one year post-injection.

January 10, 2018
·
5 min read
Biotech Beach

AmpliPhi Biosciences Announces Pricing of $4.0 Million Public Offering of Common Stock

The offering is expected to close on or about January 12, 2018, subject to customary closing conditions.

January 10, 2018
·
4 min read
Business

Cardiovascular Systems to Webcast Fiscal 2018 Second-Quarter Earnings Conference Call Wednesday, February 7

Scott Ward, Chairman, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss CSI’s results for its fiscal second quarter ended December 31, 2017, and its financial outlook.

January 10, 2018
·
1 min read
Biotech Beach

Glaukos’ iDose Travoprost Achieves Sustained IOP Reduction and Favorable Safety Profile in 12-Month Interim Cohort

The iDose delivery system continued to provide sustained reduction in intraocular pressure in a 12-month interim cohort of patients in its U.S. IND Phase II clinical trial.

January 10, 2018
·
6 min read
Biotech Bay

Kenneth Rainin Foundation Announces Grant Opportunity for IBD-Related Scientific Research

The Kenneth Rainin Foundation will accept Letters of Inquiry online for its Innovator Awards program from January 15 through February 15, 2018.

January 10, 2018
·
3 min read
Business

Spine Industry Veteran Paul Graveline Joins Spinal Elements

Mr. Graveline will have responsibility for all of the commercial efforts of Spinal Elements.

January 10, 2018
·
2 min read
BioCapital

AstraZeneca’s BYDUREON BCise Injectable Medicine Now Available in the U.S. for Patients With Type-2 Diabetes

BYDUREON BCise is a new formulation of BYDUREON injectable suspension 2mg in an improved once-weekly, single-dose autoinjector device.

January 10, 2018
·
8 min read
Business

Aimmune Therapeutics Broadens and Extends Supply Agreement With Golden Peanut and Tree Nuts for AR101 for Peanut Allergy

Aimmune today announced an expansion and extension of its exclusive supply agreement with Golden Peanut and Tree Nuts (Golden), a subsidiary of Archer Daniels Midland Company (ADM), to support the anticipated potential commercialization of AR101.

January 10, 2018
·
5 min read
Business

Sabrina Martucci Johnson Joins Aethlon Medical’s Board of Directors

Aethlon Medical today announced the appointment of Sabrina Martucci Johnson to its Board of Directors and to its Audit Committee.

January 10, 2018
·
5 min read
Pharm Country

Parkinson’s Foundation Release: Largest Clinical Study of Parkinson’s Disease Reaches 10,000-Patient Milestone, Reveals Critical Learnings

The Parkinson’s Foundation today announced the enrollment of the 10,000th Parkinson’s patient and the discovery of critical new learnings in what represents the largest clinical study of Parkinson’s disease in history.

January 10, 2018
·
4 min read